FDA EMDAC schedules to review VIVUS' Qnexa NDA for treatment of obesity

Download PDF Copy

Editorial Checklist

Reviewed

VIVUS, Inc.Dec 26 2011

NewsGuard 100/100 Score

VIVUS, Inc. (NASDAQ: VVUS) today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is scheduled to review the Company's New Drug Application (NDA) for Qnexa for the treatment of obesity on February 22, 2012. VIVUS resubmitted the NDA on October 17, 2011 seeking approval to market Qnexa in the United States. The FDA accepted the NDA for review on November 3, 2011. The target date for the FDA to complete its review of the Qnexa NDA is April 17, 2012.

Source:

Posted in: Medical Condition News | Pharmaceutical News

Tags: Diabetes, Diet, Drugs, Erectile Dysfunction, Food, New Drug Application, Obesity, Obstructive Sleep Apnea, Phentermine, Pregnancy, Sleep, Sleep Apnea, Type 2 Diabetes, Weight Loss

Comments (0)

Download PDF Copy

Suggested Reading

Obesity crisis in the U.S. expected to worsen by 2050

Obesity crisis in the U.S. expected to worsen by 2050

Vitamin D may lower blood pressure in older people with obesity

Vitamin D may lower blood pressure in older people with obesity

Tirzepatide significantly reduces weight and diabetes risk in patients with obesity and prediabetes

Tirzepatide significantly reduces weight and diabetes risk in patients with obesity and prediabetes

Study confirms bariatric surgery is safe and effective for patients with BMI over 70

Study confirms bariatric surgery is safe and effective for patients with BMI over 70

Kimchi found to significantly reduce body fat and combat obesity

Kimchi found to significantly reduce body fat and combat obesity

Ultra-processed foods drive obesity and metabolic risks

Ultra-processed foods drive obesity and metabolic risks

By 2050, two-thirds of adults and one-third of adolescents could face obesity in the US

By 2050, two-thirds of adults and one-third of adolescents could face obesity in the US

Community-led intervention curbs childhood obesity and boosts quality of life

Community-led intervention curbs childhood obesity and boosts quality of life

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Anti-obesity drugs show promise in improving cardiovascular health beyond weight loss